Koshika Soma

Tofacitinib (CP-690,550) in combination with methotrexate in patients with active rheumatoid arthritis with an inadequate response to tumour necrosis factor inhibitors: a randomised phase 3 trial

Gerd R Burmester, Ricardo Blanco, Christina Charles‐Schoeman et al. · The Lancet · 2013 · 720 citations

Medicine, Pharmacology, Pharmacotherapy +12

Efficacy and safety of tofacitinib monotherapy, tofacitinib with methotrexate, and adalimumab with methotrexate in patients with rheumatoid arthritis (ORAL Strategy): a phase 3b/4, double-blind, head-to-head, randomised controlled trial

Roy Fleischmann, Eduardo Mysler, Stephen Hall et al. · The Lancet · 2017 · 496 citations

Medicine, Pharmacology, Pharmacotherapy +12

Safety and efficacy of tofacitinib for up to 9.5 years in the treatment of rheumatoid arthritis: final results of a global, open-label, long-term extension study

J. Wollenhaupt, Eun-Bong Lee, Jeffrey R. Curtis et al. · Arthritis Research & Therapy · 2019 · 320 citations · Full text

Medicine, Clinical Sciences, Pharmacotherapy +15

The effect of tofacitinib on pneumococcal and influenza vaccine responses in rheumatoid arthritis

Kevin Winthrop, Joel C. Silverfield, Arthur Racewicz et al. · Annals of the Rheumatic Diseases · 2015 · 195 citations · Full text

Veterinary Medicine, Immunology, Pharmacotherapy +17

Cardiovascular safety findings in patients with rheumatoid arthritis treated with tofacitinib, an oral Janus kinase inhibitor

Christina Charles‐Schoeman, Pierre Wicker, Miguel Á. González‐Gay et al. · Seminars in Arthritis and Rheumatism · 2016 · 137 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +16